Literature DB >> 864831

The segments of influenza viral mRNA.

P R Etkind, D L Buchhagen, C Herz, B B Broni, R M Krug.   

Abstract

Influenza viral mRNA, i.e., complementary RNA (cRNA), isolated from infected cells , was resolved into six different species by electrophoresis in 2.1% acrylamide gels containing 6 M urea. The cRNA's were grouped into three size classes: L (large), M (medium-size), and S (small). Similarly, when gels were sliced for analysis, the virion RNA (vRNA) also distributed into six peaks because the three largest vRNA segments were closely spaced and were resolved only when the gels were autoradiographed or stained. Because of their attached polyadenylic acid [poly(A)]sequences, the cRNA segments migrated more slowly than did the corresponding vRNA segments during gel electrophoresis. After removal of the poly(A) by RNase H, the cRNA and vRNA segments comigrated, indicating that they were approximately the same size. One of the cRNA segments, S2, was shown by annealing to contain the genetic information in the vRNA segment with which it comigrated, strongly suggesting that each cRNA segment was transcribed from the vRNA segment of the same size. In contrast to the vRNA segments, which when isolated from virions were present in approximately 1:1 molar ratios, the segments of the isolated cRNA were present in unequal amounts, with the segments M2 and S2 predominating, suggesting that different amounts of the cRNA segments were synthesized in the infected cell. The predominant cRNA segments, M2 and S2, and also the S1 segment, were active as mRNA's in wheat germ extracts. The M2 cRNA was the mRNA for the nucleocapsid protein; S1 for the membrane protein; and S2 for the nonstructural protein NS1.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 864831      PMCID: PMC515725     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Isolation of intact individual species of single- and double-stranded RNA after fractionation by polyacrylamide gel electrophoresis.

Authors:  A R Schuerch; W R Mitchell; W K Joklik
Journal:  Anal Biochem       Date:  1975-05-12       Impact factor: 3.365

2.  Influenza virus genome consists of eight distinct RNA species.

Authors:  D McGeoch; P Fellner; C Newton
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

3.  Transcriptase activity and genome composition of defective influenza virus.

Authors:  W J Bean; R W Simpson
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

4.  Enhanced differential synthesis of proteins in a mammalian cell-free system by addition of polyamines.

Authors:  J F Atkins; J B Lewis; C W Anderson; R F Gesteland
Journal:  J Biol Chem       Date:  1975-07-25       Impact factor: 5.157

5.  Synthesis of influenza virus proteins in infected cells: translation of viral polypeptides, including three P polypeptides, from RNA produced by primary transcription.

Authors:  R A Lamb; P W Choppin
Journal:  Virology       Date:  1976-10-15       Impact factor: 3.616

6.  Correlation between RNA fragments of fowl plague virus and their corresponding gene functions.

Authors:  C Scholtissek; E Harms; W Rohde; M Orlich; R Rott
Journal:  Virology       Date:  1976-10-15       Impact factor: 3.616

7.  In vitro translation of influenza virus messenger RNAs.

Authors:  M B Richey; P Palese
Journal:  Virology       Date:  1976-07-15       Impact factor: 3.616

8.  Characterization of the mRNA of influenza virus.

Authors:  S E Glass; D McGeoch; R D Barry
Journal:  J Virol       Date:  1975-12       Impact factor: 5.103

9.  Cell-free translation of influenza virus mRNA.

Authors:  J Content
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

10.  Ribonuclease H of calf thymus: substrate specificity, activation, inhibition.

Authors:  J G Stavrianopoulos; A Gambino-Giuffrida; E Chargaff
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

View more
  11 in total

1.  Expression of defective-interfering influenza virus-specific transcripts and polypeptides in infected cells.

Authors:  R K Akkina; T M Chambers; D P Nayak
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

2.  Selected host cell capped RNA fragments prime influenza viral RNA transcription in vivo.

Authors:  A R Beaton; R M Krug
Journal:  Nucleic Acids Res       Date:  1981-09-11       Impact factor: 16.971

3.  Segments of influenza virus complementary RNA synthesized in vitro.

Authors:  S J Plotch; R M Krug
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

4.  Nucleotide sequences at the 5' termini of influenza virus RNAs and their transcripts.

Authors:  J J Skehel; A J Hay
Journal:  Nucleic Acids Res       Date:  1978-04       Impact factor: 16.971

5.  The coupling of transcription from influenza virions to translation in vitro.

Authors:  P D Minor; N J Dimmock
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

6.  Peptide mapping characterization of viral proteins generated in a cell-free coupled system for the transcription and translation of influenza virus mRNA.

Authors:  J Content; L De Wit; M A Horisberger
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

7.  Cloning DNA sequences from influenza viral RNA segments.

Authors:  C J Lai; L J Markoff; S Zimmerman; B Cohen; J A Berndt; R M Chanock
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

8.  In vitro transcription of defective interfering particles of influenza virus produces polyadenylic acid-containing complementary RNAs.

Authors:  P K Chanda; T M Chambers; D P Nayak
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

9.  Influenza virus messenger RNAs are incomplete transcripts of the genome RNAs.

Authors:  A J Hay; G Abraham; J J Skehel; J C Smith; P Fellner
Journal:  Nucleic Acids Res       Date:  1977-12       Impact factor: 16.971

10.  Nucleic acids of respiratory syncytial virus.

Authors:  D M Lambert; M W Pons; G N Mbuy; K Dorsch-Hasler
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.